PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

Search

Reset

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : P

Records returned : 210 (on 21 Nov 2024 at 19:47:48).

Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
Paclitaxel
No Information Returned
Paclitaxel albumin
No Information Returned
Padimate O
No Information Returned
Palbociclib
No Information Returned
Palifermin
No Information Returned
Paliperidone
No Information Returned
Palivizumab
No Information Returned
04.06.00
Palonosetron hydrochloride
Nausea and vomiting (chemotherapy induced)
Non Formulary
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
04.06.00
Palonosetron with netupitant
Nausea and vomiting (chemotherapy induced)
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD2
Pamidronate disodium
No Information Returned
01.09.04
Pancreatin
Pancreatic insufficiency
Blue
Formulations :
  • Capsules
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe by brand - product with multiple ingredients. GP initiation following specialist recommendation.
Nutrizym recommended in pregnancy / breastfeeding due to theoretical concern of phthalate content of Creon.
01.09.04
Pancreatin
Pancreatic insufficiency
Blue
Formulations :
  • Powder
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe by brand - product with multiple ingredients. GP initiation following specialist recommendation.
SASH restrict to tube-fed patients only (Pancrex V powder)
Pancuronium bromide
No Information Returned
Panitumumab
No Information Returned
Panobinostat
No Information Returned
01.03.05
Pantoprazole
Acid suppression (Adults)
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
2nd line in adults without swallowing difficulties. (Suitable for patients that cannot have animal-derived products / capsules.)
01.03.05
Pantoprazole
Gastric / Duodenal ulcer
Red
Formulations :
  • Intravenous injection (IV)
  • Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
1st-line IV PPI at ASPH, 2nd-line at RSFT
01.03.05
Pantoprazole
Zollinger-Ellison syndrome
Red
Formulations :
  • Intravenous injection (IV)
  • Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
1st-line IV PPI at ASPH, 2nd-line at RSFT
Pantothenic acid (Calcium pantothenate)
No Information Returned
04.07.02
Papaveretum
Pain
Non Formulary
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Papaverine hydrochloride
No Information Returned
04.07.01
Paracetamol
Pain
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Preferred
04.07.01
Paracetamol
Pyrexia
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Preferred
04.07.01
Paracetamol
Pyrexia
Green (see narrative)
Formulations :
  • Effervescent tablets
  • Soluble tablets
  • Suppositories
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Reserve for patients who cannot swallow solid dose forms. Soluble / effervescent preparations have a high sodium content and more expensive than ordinary tablets.
04.07.01
Paracetamol
Pyrexia
Green (see narrative)
Formulations :
  • Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
120mg/5ml and 250mg/5ml reserved for patients who cannot swallow solid dose forms. Non-formulary: Paracetamol oral suspension 500mg/5ml. Much more expensive. Use a soluble formulation.
04.07.01
Paracetamol
Pain
Green (see narrative)
Formulations :
  • Effervescent tablets
  • Soluble tablets
  • Suppositories
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
R
Important
Reserve for patients who cannot swallow solid dose forms. Soluble / effervescent preparations have a high sodium content and more expensive than ordinary tablets. Suppositories for use when oral route is not suitable
04.07.01
Paracetamol
Pain
Green (see narrative)
Formulations :
  • Oral suspension
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
R
Important
120mg/5ml and 250mg/5ml reserved for patients who cannot swallow solid dose forms or where sodium content of dispersible preparations is a problem. Non-formulary: Paracetamol oral suspension 500mg/5ml. Much more expensive. Use a soluble formulation.
04.07.01
Paracetamol
Pain
Red
Formulations :
  • Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
SA
Important
Prescribe in milligrams for doses <1g. Review infusion prescriptions after 48-72 hours. Note risk of overdose with IV paracetamol.
04.07.01
Paracetamol
Pyrexia
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
SA
Important
Prescribe in milligrams for doses <1g Review infusion prescriptions after 48-72 hours. Note risk of overdose with IV paracetamol.
Paracetamol and caffeine
No Information Returned
Paracetamol and ibuprofen
No Information Returned
Paracetamol and phenylephrine hydrochloride
No Information Returned
Paracetamol combined preparations
No Information Returned
Paraffin hard
No Information Returned
Paraffin soft white
No Information Returned
11.08.01
Paraffin soft yellow
Dry eyes
Non Formulary
Formulations :
  • Eye ointment
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
11.08.01
Paraffin with lubricant
Dry eyes
Green
Formulations :
  • Eye ointment
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Moderate dry eye. Prescribe by brand: 1st line = HydraMed Night 2nd line = Moistueyes, Xailin Night, Hylo Night
Paraldehyde
No Information Returned
Parathyroid hormone
No Information Returned
Parecoxib sodium
No Information Returned
Paricalcitol
No Information Returned
05.03.03
Paritaprevir/ritonavir/ombitasvir
Hepatitis C
Red
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NHSE
Paromomycin sulfate
No Information Returned
Paroxetine hydrochloride
No Information Returned
Pasireotide
No Information Returned
Patiromer calcium
No Information Returned
Pazopanib
No Information Returned
Pegaptanib sodium
No Information Returned
Pegaspargase
No Information Returned
Pegfilgrastim
No Information Returned
Peginterferon alfa
Hepatitis B
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
R
NHSE
NICE
Important
RESTRICTED - to be used under advice from Consultant Microbiologist
05.03.03
Peginterferon alfa
Hepatitis C
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
R
NHSE
NICE
Peginterferon alpha
No Information Returned
Peginterferon beta
No Information Returned
08.02.04
Peginterferon beta-1a
Multiple sclerosis
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NHSE
BlueTeq
Pegvisomant
No Information Returned
Pembrolizumab
No Information Returned
Pemetrexed
No Information Returned
Penciclovir
No Information Returned
10.01.03
Penicillamine
Rheumatoid arthritis
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Severe disease only
05.04.08
Pentamidine isetionate
Pneumonia
Red
Formulations :
  • Injection
  • Nebules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Follow local guidelines on the use of antimicrobials
Pentazocine hydrochloride
No Information Returned
Pentazocine lactate
No Information Returned
02.08.02
07.04.03
Pentosan polysulfate sodium
Glycosaminoglycan layer therapy (GAG therapy)
Red
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
R
NICE
Important
Urology consultants only
Pentostatin
No Information Returned
02.06.04
Pentoxifylline
Peripheral arterial disease
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
01.02.00
Peppermint oil
Muscle spasm
Green (see narrative)
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
The gastro-resistant capsules (Mintec®) are the most cost-effective option for Primary Care. The modified-release capsules (Colpermin) contain arachis oil - not be taken by patients with a known peanut allergy
01.01.02
Peptac
Dyspepsia
Green (see narrative)
Formulations :
  • Suspension
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
RSCH use in children age 6-12 years only.
04.08.01
Perampanel
Epilepsy
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Requires specialist initiation and supply for at least 12 weeks prior to a transfer of care to primary care prescribers
04.09.01
Pergolide mesilate
Parkinson's disease
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Not a 1st-line treatment option. On-going toxicity monitoring required
Pericyazine
No Information Returned
02.05.05
Perindopril arginine
Hypertension
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
Important
NHS England guidance DO NOT ROUTINELY PRESCRIBE
Perindopril arginine with diuretic
No Information Returned
02.05.05
Perindopril erbumine
Heart failure
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
2mg, 4mg and 8mg tablets. Do not prescribe as perindopril arginine.
02.05.05
Perindopril erbumine
Hypertension
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Important
2mg, 4mg and 8mg tablets
Perindopril erbumine with diuretic
No Information Returned
Perindopril tosilate
No Information Returned
Perindopril tosilate/indapamide
No Information Returned
Perindopril with calcium channel blocker
No Information Returned
Permethrin
No Information Returned
Perphenazine
No Information Returned
Pertuzumab
No Information Returned
04.07.02
Pethidine hydrochloride
Pain
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
CD
Important
Acute pain, including obstetric analgesia
04.07.02
Pethidine hydrochloride
Pain
Non Formulary
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
CD
Phased formulations of ethinylestradiol
No Information Returned
Phenazone/lidocaine
No Information Returned
04.03.02
Phenelzine sulfate
Depression
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Initiation and stabilisation by specialist for a minimum of 6 months before transfer of prescribing to primary care.
Phenindione
No Information Returned
04.08.01
04.08.02
Phenobarbital
Epilepsy
Blue
Formulations :
  • Elixir
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
CD
Important
Ensure that the patient is maintained on a specific manufacturer’s product
04.08.01
04.08.02
Phenobarbital
Epilepsy
Blue
Formulations :
  • Liquid
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
CD
Un
Important
Ensure that the patient is maintained on a specific manufacturer’s product
Unlicensed phenobarbital liquid 50mg/5ml (sugar and alcohol free) for paediatric use (as recommended by the RCPCH and NPPG).
04.08.01
04.08.02
Phenobarbital
Status epilepticus
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
CD
Phenobarbital sodium
No Information Returned
01.07.03
13.10.05
Phenol
Haemorrhoids
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Phenolphthalein and rhubarb
No Information Returned
Phenothrin
No Information Returned
02.05.04
02.06.04
Phenoxybenzamine hydrochloride
Hypertension in phaeochromocytoma
Red
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Phenoxyethanol
No Information Returned
05.01.01
Phenoxymethylpenicillin (Penicillin V)
Bacterial infection
Green
Formulations :
  • Oral suspension
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials
Phenprocoumon
No Information Returned
02.05.04
Phentolamine mesilate
Hypertension in phaeochromocytoma
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
U
Important
Unlicensed.
Phentolamine/aviptadil
No Information Returned
Phenylbutazone
No Information Returned
02.07.02
11.05.00
12.02.02
Phenylephrine hydrochloride
Mydriasis
Red
Formulations :
  • Eye drops (unit dose)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
02.07.02
11.05.00
12.02.02
Phenylephrine hydrochloride
Hypotension
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
11.05.00
Phenylephrine hydrochloride and tropicamide
Mydriasis
Red
Formulations :
  • Ophthalmic insert
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
MYDRIASERT 5.4mg/0.28mg Ophthalmic Insert
Phenylprop hydrochloride/chlorphenamine maleate
No Information Returned
Phenylpropanolamine hydrochloride
No Information Returned
04.08.01
04.08.02
Phenytoin
Epilepsy
Blue
Formulations :
  • Capsules
  • Oral suspension
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
SA
Important
Ensure that the patient is maintained on a specific manufacturer’s product. Phenytoin sodium is NOT EQUIVALENT to Phenytoin base (suspension). When switching between products, 100mg of phenytoin sodium is approximately equivalent to 92mg of phenytoin base.
04.08.01
04.08.02
Phenytoin
Status epilepticus
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Phenytoin sodium
No Information Returned
Pholcodine
No Information Returned
Phosphates
No Information Returned
01.06.04
Phosphates (Rectal)
Constipation
Green
Formulations :
  • Enema
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
SA
Important
Contraindicated in patients with CKD, dehydration and heart failure (among others).
Phytomenadione
No Information Returned
11.06.00
12.03.05
Pilocarpine hydrochloride
Glaucoma / ocular hypertension
Blue
Formulations :
  • Eye drops
  • Eye drops (preservative free)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care.
Pilocarpine nitrate
No Information Returned
Pimecrolimus
No Information Returned
Pimozide
No Information Returned
Pindolol
No Information Returned
Pindolol with diuretic
No Information Returned
Pioglitazone hydrochloride
No Information Returned
05.01.01
Piperacillin sodium/tazobactam sodium
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
SA
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Contra-indicated in Penicillin Allergy
Piperaquine phosphate/artenimol
No Information Returned
Piperazine
No Information Returned
Pipobroman
No Information Returned
Pipotiazine palmitate
No Information Returned
04.08.01
04.09.03
Piracetam
Epilepsy
Red
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Pirenzepine
No Information Returned
03.11.01
Pirfenidone
Idiopathic pulmonary fibrosis
Red
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
NHSE Specialist Centre only
10.01.01
10.03.02
Piroxicam
Osteoarthritis
Green
Formulations :
  • Gel
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Preferred
0.5% gel. Low cost option for primary care.
04.04.00
Pitolisant hydrochloride
Narcolepsy
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
05.01.01
Pivmecillinam hydrochloride
Urinary Tract Infection (UTIs)
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials
04.07.04
Pizotifen
Migraine (prevention)
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Review existing patients and consider alternative. Discontinuation of pizotifen requires gradual withdrawal.
Pizotifen malate
No Information Returned
Plerixafor
No Information Returned
Pneumococcal
No Information Returned
Podophyllotoxin
No Information Returned
Podophyllum resin
No Information Returned
Policosanol
No Information Returned
Polihexanide
No Information Returned
Poliomyelitis
No Information Returned
Pollen allergy preparations
No Information Returned
Polymyxin B sulphate
No Information Returned
Polymyxins
No Information Returned
Polynoxylin
No Information Returned
Polysaccharide-iron complex
No Information Returned
Polythiazide
No Information Returned
11.08.01
Polyvinyl alcohol
Dry eyes
Non Formulary
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
Pomalidomide
No Information Returned
Ponatinib
No Information Returned
Porfimer sodium
No Information Returned
05.02.01
Posaconazole
Fungal infection
Red
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Potassium bicarbonate
No Information Returned
Potassium bromide
No Information Returned
Potassium chloride
No Information Returned
07.04.03
Potassium citrate
Alkalinisation of urine
Green
Formulations :
  • Effervescent tablets
  • Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Can be purchased from a pharmacy
Potassium hydroxyquinoline sulphate
No Information Returned
Potassium iodate
No Information Returned
Potassium iodide
No Information Returned
Potassium permanganate
No Information Returned
07.02.02
11.08.02
Povidone iodine
Ocular surgery
Red
Formulations :
  • Eye drops (preservative free)
  • Eye drops (preservative free, unit dose)
  • Intravitreal injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
07.02.02
11.08.02
Povidone iodine
Bacterial vaginosis
Non Formulary
Formulations :
  • Pessaries
  • Vaginal gel
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Povidone K 25
No Information Returned
Povidone-iodine
No Information Returned
Powder 1 - 2.2 kcal/ml soup (0913011)
No Information Returned
Powder 1.5 kcal/ml smoothie (0913011)
No Information Returned
Powder 1.6 kcal/ml milkshake (0913011)
No Information Returned
Powder 2 kcal/ml m/sk higher volume, higher energy (0913011)
No Information Returned
Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011)
No Information Returned
Powdered opium
No Information Returned
04.09.01
Pramipexole
Restless Leg Syndrome
Green
Formulations :
  • Immediate release tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Preferred
Patients with severe symptoms, who are obese, co-morbid depression, increased risk of falls or cognitive impairment
04.09.01
Pramipexole
Parkinson's disease
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
NICE
04.09.01
Pramipexole
Parkinson's disease
Blue
Formulations :
  • Modified release tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
NICE
04.09.01
Pramipexole
Parkinson's disease (neuroprotective therapy)
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
06.04.01
06.04.03
Prasterone
Vaginal atrophy
Blue
Formulations :
  • Pessaries
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Initiation on specialist recommendation only. For severe dryness where other treatments are ineffective / contraindicated.
02.09.00
Prasugrel
Prevention of atherothrombotic events - Acute Coronary Syndrome
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF NICE SPC
NICE
Important
Restricted to cardiology consultants. Clopidogrel is the preferred option. Specialist initiation and at least one month supply before transfer to primary care
02.12.00
Pravastatin sodium
Lipid modification
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Praziquantel
No Information Returned
02.05.04
07.04.01
Prazosin hydrochloride
Heart failure
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
02.05.04
07.04.01
Prazosin hydrochloride
Hypertension
Green (see narrative)
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
U
Important
Only the 500mcg tablets are licensed in the UK. 2mg and 5mg tablets as special order or import only (much more expensive)
02.05.04
07.04.01
Prazosin hydrochloride
Benign prostatic hyperplasia
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
01.05.02
11.04.01
06.03.02
Prednisolone
Inflammatory bowel disease
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Tablets can be dispersed for immediate administration.
01.05.02
11.04.01
06.03.02
Prednisolone
Inflammatory bowel disease
Green
Formulations :
  • Soluble tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
R
Important
Paediatrics only at SASH. Paediatrics and oncology at ASPH
01.05.02
11.04.01
06.03.02
Prednisolone
Inflammatory bowel disease
Green
Formulations :
  • Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
R
Important
Paediatric doses and NG/NJ tube only
01.05.02
11.04.01
06.03.02
Prednisolone
Eye inflammation
Blue
Formulations :
  • Eye drops
  • Eye drops (preservative free, unit dose)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
0.5%, 1% drops. Short-term use only. Primary Care prescribing on specialist recommendation.
01.05.02
11.04.01
06.03.02
Prednisolone
Inflammatory bowel disease
Non Formulary
Formulations :
  • Gastro-resistant tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Enteric coated tablets - non-formulary
01.05.02
11.04.01
06.03.02
Prednisolone
Inflammatory bowel disease
Non Formulary
Formulations :
  • Foam enema
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
Important
Budesonide rectal foam is preferred. Steroid safety considerations
Prednisolone acetate
No Information Returned
Prednisolone sodium metasulphobenzoate
No Information Returned
Prednisolone sodium phosphate
No Information Returned
Prednisone
No Information Returned
04.07.03
04.07.04
04.08.01
Pregabalin
Restless Leg Syndrome
Green
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Un
Important
Preferred
Patients with severe sleep disturbance, RLS-related / co-morbid pain or history of impulse control disorder
04.07.03
04.07.04
04.08.01
Pregabalin
Pain (Neuropathic)
Green (see narrative)
Formulations :
  • Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
CD
04.07.03
04.07.04
04.08.01
Pregabalin
Pain (Neuropathic)
Green (see narrative)
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
CD
SA
Important
Gabapentin is preferred due to lower potential for misuse. Pregabalin capsules more cost effective than tablets
04.07.03
04.07.04
04.08.01
Pregabalin
Epilepsy
Blue
Formulations :
  • Capsules
  • Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
CD
Important
Capsules are more cost effective than tablets
04.07.03
04.07.04
04.08.01
Pregabalin
Pain
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
Important
Not for chronic or acute, non-malignant pain. See separate formulary entry for use in neuropathic pain
04.07.03
04.07.04
04.08.01
Pregabalin
Migraine (prevention)
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Preparations for other vaginal infections
No Information Returned
Pridinol
No Information Returned
Pridinol mesilate
No Information Returned
Prilocaine hydrochloride
No Information Returned
Primaquine
No Information Returned
04.08.01
04.09.03
Primidone
Epilepsy
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe by brand - ensure patient is maintained on a specific product.
04.08.01
04.09.03
Primidone
Essential tremor
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Initiation by specialist before transfer to Primary Care
Pristinamycin
No Information Returned
10.01.04
Probenecid
Hyperuricaemia and Gout
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
U
Important
Named-patient supply only
02.03.02
Procainamide hydrochloride
Arrhythmias
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
U
Important
Unlicensed
Procaine hydrochloride
No Information Returned
Procarbazine hydrochloride
No Information Returned
04.06.00
Prochlorperazine maleate
Vestibular disorders
Green
Formulations :
  • Buccal tablets
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
04.06.00
Prochlorperazine maleate
Nausea and vomiting (pregnancy)
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Un
Important
Preferred
1st line treatment option.
04.06.00
Prochlorperazine maleate
Nausea and vomiting
Green
Formulations :
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Oral solution for patients with swallowing difficulties.
04.06.00
Prochlorperazine maleate
Nausea and vomiting (pregnancy)
Green (see narrative)
Formulations :
  • Buccal/sublingual
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Un
Important
An option for patients with swallowing difficulties
04.06.00
Prochlorperazine maleate
Nausea and vomiting (post operative)
Red
Formulations :
  • Injection
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
04.06.00
Prochlorperazine maleate
Nausea and vomiting
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
04.06.00
Prochlorperazine maleate
Nausea and vomiting (chemotherapy induced)
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Prochlorperazine mesilate
No Information Returned
04.09.02
Procyclidine hydrochloride
Parkinson's disease
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Proflavine
No Information Returned
Proflavine hemisulphate
No Information Returned
06.04.01
Progesterone
Menopausal disorders
Green (see narrative)
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Preferred
Prescribe generically. Micronised progesterone oral capsules.
Proguanil hydrochloride
No Information Returned
Proguanil hydrochloride with atovaquone
No Information Returned
Promazine hydrochloride
No Information Returned
03.04.01
04.06.00
Promethazine hydrochloride
Vestibular disorders
Green
Formulations :
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
03.04.01
04.06.00
Promethazine hydrochloride
Nausea and vomiting (pregnancy)
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Un
Important
Preferred
1st line treatment option.
03.04.01
04.06.00
Promethazine hydrochloride
Nausea and vomiting
Green
Formulations :
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Oral solution for patients with swallowing difficulties.
03.04.01
04.06.00
Promethazine hydrochloride
Nausea and vomiting (pregnancy)
Green (see narrative)
Formulations :
  • Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Un
Important
An option for patients with swallowing difficulties
03.04.01
04.06.00
Promethazine hydrochloride
Nausea and vomiting
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
04.06.00
Promethazine teoclate
Nausea and vomiting (pregnancy)
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Un
Important
Preferred
1st line treatment option. This is a lower cost promethazine option for primary care but note difference in CKS recommended dose.
04.06.00
Promethazine teoclate
Vestibular disorders
Green
Formulations :
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
This is a lower cost promethazine option for primary care but note difference in recommended doses between teoclate and hydrochloride salts
02.03.02
Propafenone hydrochloride
Arrhythmias
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Specialist initiation and at least one month supply before transfer to primary care
11.03.01
Propamidine isetionate
Eye infections
Red
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
0.1% eye drops
01.02.00
Propantheline bromide
Muscle spasm
Non Formulary
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Hyoscine butylbromide is the preferred treatment option for smooth muscle spasm.
07.04.02
Propiverine hydrochloride
Overactive bladder (adults)
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
Propofol
No Information Returned
02.04.00
04.07.04
Propranolol hydrochloride
Migraine (prevention)
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
02.04.00
04.07.04
Propranolol hydrochloride
Arrhythmias
Green
Formulations :
  • Modified release capsules
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
02.04.00
04.07.04
Propranolol hydrochloride
Angina
Green
Formulations :
  • Modified release capsules
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
02.04.00
04.07.04
Propranolol hydrochloride
Hypertension
Green (see narrative)
Formulations :
  • Modified release capsules
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Important
Not a preferred beta blocker for hypertension. The cardio-selective betablockers, bisoprolol or atenolol are the preferred options
02.04.00
04.07.04
Propranolol hydrochloride
Hypertension in phaeochromocytoma
Blue
Formulations :
  • Modified release capsules
  • Oral solution
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Only in combination with an alpha-blocker. Transfer of prescribing to primary care only after initiation and stabilisation by the specialist.
Propranolol hydrochloride with diuretic
No Information Returned
Propylthiouracil
No Information Returned
02.08.03
Protamine sulfate
Anticoagulation reversal
Red
Formulations :
  • Intravenous injection (IV)
  • Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Heparin reversal. Heamtology only
Protamine zinc insulin
No Information Returned
Protein C concentrate
No Information Returned
Protirelin
No Information Returned
11.07.00
Proxymetacaine hydrochloride
Local anaesthesia (eye)
Red
Formulations :
  • Eye drops (preservative free, unit dose)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
0.5% preservative free eye drops
01.06.07
Prucalopride
Constipation
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Important
Only after a trial of at least 2 other classes of laxative at the highest recommended, tolerated doses. Consider stopping after 4 weeks if not effective.
Pseudoephedrine hydrochloride
No Information Returned
Pseudoephedrine hydrochloride combinations
No Information Returned
Pseudoephedrine hydrochloride/dextromethorphan hydrobromide
No Information Returned
Pseudoephedrine sulfate combinations
No Information Returned
05.01.09
Pyrazinamide
Tuberculosis
Red
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Liaise with Chest Physician. Patients with multi-drug resistant TB should be treated by a specialist centre.
10.02.01
Pyridostigmine bromide
Myasthenia gravis
Blue
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
10.02.01
Pyridostigmine bromide
Orthostatic hypotension
Red
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
3rd line. Off-label use for patients who have not responded to midodrine or fludrocortisone
Pyridoxine hydrochloride
No Information Returned
Pyrimethamine
No Information Returned
Pyrimethamine with dapsone
No Information Returned
Pyrimethamine with sulfadoxine
No Information Returned
 

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq
BlueTeq form to be completed
NICE
NICE

Traffic Light Status Key

Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Black
Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.
Amber Star
Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)
See Below
Please add a description.
N/A
Please add a description.
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green - Black
Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.
See narrative
See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)
Do not initiate in new patients
These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More